23.04.2025 • News
Roche Invests $50 Billion in Pharmaceuticals & Diagnostics
Roche recently announced that it will invest $50 billion (€43.8 billion) into the United States in the next five years.
investment
15.04.2025 • News
Cellasto Invests €60 million to Establish Second Plant in China
Cellasto, the world leader in Noise, Vibration and Harshness (NVH) components, is investing roughly €60 million to establish a second plant in Shanghai, China.
11.04.2025 • News
Asahi Kasei Launches Life Science Division to Boost Bioprocess Innovation
To meet growing demand from the pharmaceutical industry, Asahi Kasei has established Asahi Kasei Life Science to operate its bioprocess businesses under a new organizational structure.
10.04.2025 • News
Novo Nordisk Invests $1.09 Billion in Brazil
Novo Nordisk continues its sizeable manufacturing investments to meet increasing drug demands.
09.04.2025 • News
Solvay Expands Rare Earths Production in Europe
Solvay has officially inaugurated its rare earths production line for permanent magnets at the La Rochelle facility, marking a significant milestone in the Group’s commitment to meeting Europe’s strategic goals.
07.04.2025 • News
Boehringer Ingelheim Opens New R&D Center in Basel
NBE Therapeutics (NBE), a wholly owned subsidiary of Boehringer Ingelheim, officially opened its new ADC R&D facility in Basel.
01.04.2025 • News
Covestro to Launch Automated Lab for Coatings and Adhesives Development
New facility will focus on crosslinkers and binders, with the potential to test tens of thousands of formulations per year. Digitalization and automation enable data-driven research and development, while networked robotics allow more efficient data generation for segment-specific application testing.
28.03.2025 • News
Vynova Alkoxides Awards Engineering Contract for New Plant
Vynova Alkoxides GmbH is beginning the construction of a new alcoholates plant at Chemiepark Lülsdorf GmbH in Lülsdorf, Germany.
27.03.2025 • News
J&J to Invest $55 Billion in US Operations
US healthcare giant Johnson & Johnson (J&J) has unveiled plans to invest over $55 billion in the US over the next four years. This significant investment marks a 25% increase compared to the previous four years, the company said.
24.03.2025 • News
OMV Opens Plant for Plastic Recycling
OMV has announced the expansion of its innovative ReOil technology at the Schwechat refinery near Vienna.
24.03.2025 • News
AstraZeneca to Establish Global Drug Research Center in Beijing
Britain’s AstraZeneca wants to invest $2.5 billion in Beijing, China to establish its sixth global strategic R&D center.
19.03.2025 • News
Arkema Launches Acrylic Acid Purification Project
Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.
11.03.2025 • News
Syngene Acquires its First US Manufacturing Facility
Syngene, a global contract research, development, and manufacturing organization (CRDMO), recently announced the acquisition of its first biologics site in the USA – fitted with multiple monoclonal antibody (mAbs) manufacturing lines.
10.03.2025 • News
Axplora Expands Capabilities at Le Mans Site
Axplora, an API small molecule and ADC (antibody-drug conjugate) manufacturer, is strengthening its position in the commercial manufacturing ADCs by launching a cutting-edge payload manufacturing workshop at its Le Mans site (France).
10.03.2025 • News
Adragos Pharma Commissions New Liquid Filling Line at German Site
German contract development and manufacturing organization (CDMO) Adragos Pharma has completed a €4 million project to install and commission a new, cGMP-compliant liquid drug filling line and associated cartoning machine at its plant in Leipzig, Germany.
06.03.2025 • News
CordenPharma Expands Peptide Manufacturing Platform in Switzerland
Contract development and manufacturing organization (CDMO) CordenPharma has finalized plans to establish a new peptide manufacturing facility in Switzerland located at Getec Park in Muttenz near Basel. This investment is part of the company’s growth initiatives with a more than €1 billion strategic investment in peptide development and manufacturing.
03.03.2025 • News
Toray Opens R&D Center in Taiwan for Semiconductors
Toray Industries has opened the Toray Taiwan Technical Center. This new facility aims to enhance research and development in advanced semiconductor technologies and materials, and provide technical services in the Taiwan market, which plays a significant role in the global semiconductor supply chain.
27.02.2025 • News
Lilly to Expand US Drug Manufacturing with $27 Billion Investment
Eli Lilly plans to invest $27 billion to bolster its domestic medicine production across several therapeutic areas by building four new manufacturing sites in the US.
27.02.2025 • News
Arkema to Increase its PVDF Capacity in North America
The 15% capacity expansion of Arkema’s PVDF production site in Calvert City, Kentucky, represents an investment of approximately $20 million (€19 million).
25.02.2025 • News
BASF Expands Cellasto MCU Production in India
BASF India Ltd. has broken ground on a new plant to increase the production capacity of its Cellasto microcellular polyurethane (MCU) in Dahej, India.
24.02.2025 • News
Nouryon Doubles Capacity of Chromatography Media in Sweden
Nouryon plans to expand its chromatography media manufacturing facility in Bohus, Sweden, doubling the site’s capacity. Construction will begin in early 2025, and the start of production is expected in early 2027, the company said.
24.02.2025 • News
Henkel Opens New Application Center in South Korea
Henkel recently announced the opening of its new Application Center in Busan, South Korea, marking a significant investment in the global sports & fashion industry.
19.02.2025 • News
Lanxess Opens Application Development Center in India
German specialty chemicals company Lanxess inaugurated its India Application Development Center (IADC) in Mumbai.
TotalEnergies and Air Liquide to Invest €1 Billion in Dutch Green Hydrogen Projects
TotalEnergies and Air Liquide have signed agreements to develop two projects in the Netherlands, for the production and delivery of some 45,000 t/y of green hydrogen produced using renewable power, generated mostly by the OranjeWind offshore wind farm, developed by TotalEnergies (50%) and RWE (50%).
12.02.2025 • News
Fujifilm Ramps up Capacity for Semiconductor Materials in Belgium
Fujifilm plans to invest approximately €25 million to install new production facilities for chemical mechanical planarization (CMP) slurries, which are used in advanced semiconductors, as well as enhance existing facilities for photolithography-related materials at its site in Antwerp, Belgium.
11.02.2025 • News
First Companies to Produce at Oman’s Ladayn Polymer Park
Global integrated energy group OQ announced that three companies, representing a combined investment of $42 million, will start operations at Oman’s Ladayn Polymer Park in early 2025.
05.02.2025 • News
Repsol Greenlights €800 Million Ecoplant Investment
Spanish energy and petrochemicals group Repsol has approved an investment of more than €800 million to build its Ecoplant in the area of Tarragona, Spain. The first of its kind in Europe, the facility will use urban waste to produce renewable fuels and circular products through gasification, the company said.
04.02.2025 • News
Upperton Completes Sterile Manufacturing Facility in UK
UK contract development and manufacturing organization (CDMO) Upperton Pharma Solutions, has completed its new sterile manufacturing facility in Nottingham, UK, expanding its capacity in addition to its existing 50,000-square-foot site at Trent Gateway.
04.02.2025 • News
Solvias Opens New Testing Center in North Carolina, US
Solvias, a Switzerland-headquartered provider of chemistry, manufacturing, and control (CMC) analytics, has opened the first phase of its 50,000-square-foot testing center for biologics and cell and gene therapy in Research Triangle Park (RTP), North Carolina, US.
30.01.2025 • News
AstraZeneca Plans $570 Million Investment in Canada
To support the move to a larger office facility in the Greater Toronto Area, Ontario, AstraZeneca plans to invest $570 million in Canada, creating more than 700 jobs.
27.01.2025 • News
Amgen Opens New Drug Substance Facility in the US
At the end of last week, US biotech Amgen officially opened its newest drug substance facility in Holly Springs, North Carolina, US. The opening day also saw the groundbreaking of a further $1 billion expansion at the North Carolina site, announced less than two months ago.
13.01.2025 • News
AkzoNobel Invests €22 Million Streamlining France Operations
AkzoNobel has proposed a €22 million investment to make its Montataire site a flagship for decorative paint production in France.
30.12.2024 • News
Carbios Postpones Construction of PET Bio-Recycling Facility in France
French green chemistry company Carbios announced that it is postponing the construction of its PET bio-recycling plant in Longlaville for six to nine months due to delayed funding pending completion of additional financing under satisfactory conditions. The company aims to complete the financing as soon as possible to meet market needs from 2027. Carbios expects to sign several binding commercial contracts in the first half of 2025.
27.12.2024 • News
Messer Starts Operation of New Green CO2 Plant in Czechia
German family-owned industrial gases producer Messer has started operations at a new plant for the production of green carbon dioxide (CO2) at its Vrdy site in the Czech Republic.
18.12.2024 • News
Toray to Build Pilot Facility for All-Carbon CO2 Separation Membrane in Japan
Japan’s Toray Industries plans to install a pilot facility for its all-carbon carbon dioxide (CO2) separation membrane at its plant in Shiga, Japan.
AstraZeneca
Sterling Pharma Solutions
AmbioPharm, Inc.
European Chemical Industry Council - Cefic aisbl
Trinseo LLC
Accenture
Wacker Chemie
Syngene International Ltd.
WeylChem International GmbH
SchüllerConsulting
SABIC Europe
Avantium
Lonza AG
Navin Molecular
Roche Gruppe
Nouryon
Vynova Group
Oxea
Cambrex Corporation
Bayer AG
Enzene Biosciences Ltd
Covestro
Akzo Nobel GmbH
Capchem Technology USA Inc.
IMCD Group B.V.
Sandoz AG
A.T. Kearney GmbH
Cepsa Química/Cepsa Chemicals
OCI Global
Syensqo
Chemical Market Reporter
Carbios
LANXESS Deutschland GmbH
DuPont Company
Ineos
Hovione
Boehringer Ingelheim
Aurigene Pharmaceutical Services Ltd.
BASF AG
Eli Lilly and Company
Siegfried
Solenis LLC
Arkema
Aragen Life Sciences Ltd.
Thyssenkrupp Nucera AG & Co. KGaA
Cambrex Corporation
Solvay
AkzoNobel
Orion S.A.
Asahi Kasei Europe GmbH